• Login
    View Item 
    •   DSpace Home
    • Stony Brook University
    • Stony Brook Theses & Dissertations [SBU]
    • View Item
    •   DSpace Home
    • Stony Brook University
    • Stony Brook Theses & Dissertations [SBU]
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsDepartmentThis CollectionBy Issue DateAuthorsTitlesSubjectsDepartment

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Screening for Steroid-Derived Immunomodulatory Metabolites Biosynthesized by Mycobacterium tuberculosis (M. tuberculosis)

    Thumbnail
    View/Open
    Jin_grad.sunysb_0771M_11194.pdf (2.072Mb)
    Date
    1-Dec-12
    Author
    Jin, Xiaoqian
    Publisher
    The Graduate School, Stony Brook University: Stony Brook, NY.
    Metadata
    Show full item record
    Abstract
    Tuberculosis (Tb) is a serious worldwide threat to human health killing 1.4 million people every year. Mycobacterium tuberculosis (M. tuberculosis), the causative agent for Tb, has infected 30% of the world's population. The emergence of multidrug, extensively drug, and total drug resistant organisms (MDR/XDR/TDR TB) creates an urgent demand to develop new drugs with novel mechanisms to be effective against both sensitive and drug-resistant strains of M. tuberculosis. The cholesterol metabolism pathway in M. tuberculosis is important for mycobacterial survival in the host macrophage. We proposed that cholesterol serves as a starting material for biosynthesis of steroid-derived immunomodulators that down-regulate the host immune response in the intracellular environment. Therefore, identifying the metabolites, which are hypothesized to enable M. tuberculosis to modulate and evade the host immune response, can help elucidate the cholesterol metabolic pathways, presenting an attractive target for new drugs. To determine whether M. tuberculosis produces immunomodulatory compounds that act as agonists or antagonists of nuclear receptors, our objective is to use bioassays to identify and isolate metabolites biosynthesized from cholesterol by Mycobacterium Smegmatis (M. smegmatis). We set up the procedure for purification and analysis of low-density lipoprotein-cholesterol (LDL-cholesterol). By measuring the changes in fluorescence polarization, we also set up a screening assay for metabolites from M. smegmatis grown on LDL-cholesterol against glucocorticoid receptor.
    Description
    66 pg.
    URI
    http://hdl.handle.net/1951/59708
    Collections
    • Stony Brook Theses & Dissertations [SBU] [1955]

    SUNY Digital Repository Support
    DSpace software copyright © 2002-2023  DuraSpace
    Contact Us | Send Feedback
    DSpace Express is a service operated by 
    Atmire NV
     

     


    SUNY Digital Repository Support
    DSpace software copyright © 2002-2023  DuraSpace
    Contact Us | Send Feedback
    DSpace Express is a service operated by 
    Atmire NV